NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Sertraline


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
ARYx Therapeutics Reports Second Quarter 2009 Results
2009 AUG 24 ... amiodarone (atrial fibrillation), lovastatin and fenofibrate (cholesterol lowering), and sertraline (depression), and were taken by about 30% of the enrolled patients. In patients with a ...
Subject: ARYx Therapeutics, Inc.
Price: $3.00
*
Data from University of Texas, Department of Clinical Sciences advance knowledge in life sciences
2009 NOV 23 ... differences in remission among within-class, out-of-class or dual-action agents: sertraline (27%), bupropion-sustained release (26%) and venlafaxine-extended release (25%). In step ...
Subject: Life Sciences
Price: $3.00
*
Data on depression described by N. Sawada et al
2009 AUG 31 ... antidepressant, 63.1% of these patients did so without consulting their physicians. Sertraline use was associated with a higher persistence rate at month 6 (odds ratio 2.59 in ...
Subject: Depression
Price: $3.00
*
Former Pfizer Global R&D President John LaMattina Joins PureTech Ventures as Senior Partner; PureTech Announces Partner Promotions
2009 NOV 23 ... Pharmacia, Post-Traumatic Stress Disorder, Pregabalin, Rheumatoid Arthritis, Selzentry, Sertraline Hydrochloride, Tarceva, Therapy, Treatment, Zoloft, PureTech Ventures. This ...
Subject: Diabetes
Price: $3.00
*
New depression study findings have been reported from G.A. Decarvalho et al
2009 SEP 7 ... (SSRIs) on thyroid function. This study aimed to establish the effects of fluoxetine and sertraline treatments on thyroid function and thyroid autoimmunity in patients with major ...
Subject: Depression
Price: $3.00
*
New findings reported from Magna Graecia University describe advances in dementia
2009 SEP 14 ... In this recent report, researchers in Italy conducted a study "To describe a case of sertraline-induced rhabdomyolysis in an elderly patient with dementia and comorbidities. SUMMARY: A ...
Subject: Dementia
Price: $3.00
*
New life sciences findings from New York University, Medical Department described
2009 AUG 3 ... "Sertraline and fluoxetine are selective serotonin re-uptake inhibitors (SSRIs) that are widely ...
Subject: Life Sciences
Price: $3.00
*
Obama's Healthcare Debate and Dr. Chao's 8 Herbal Ounces of Prevention
2009 OCT 12 ... Hydrochloride, Paxil, Pediatrics, Pharmaceuticals, Phosphodiesterase Inhibitor, Sertraline Hydrochloride, Therapy, Treatment, Type 2 Diabetes Mellitus, Weight Gain, Wellness, ...
Subject: Type 2 Diabetes
Price: $3.00
*
Popular Breast Cancer Drug Used with Certain Antidepressants Puts New Jersey Women at Risk
2009 AUG 10 ... inhibitors (SSRI), for example Prozac (fluoxetine), Paxil (paroxetine) and Zoloft (sertraline), have up to twice the chance of having a recurrence of the disease. In a ...
Subject: Breast Cancer
Price: $3.00
*
Recent findings from M. Bourin and co-authors highlight research in depression
2009 OCT 19 ... co-administration of aripiprazole with selective serotonin reuptake inhibitors (SSRIs; sertraline, paroxetine, and citalopram), selective serotonin-norepinephrine reuptake inhibitors ...
Subject: Depression
Price: $3.00
*
Report summarizes depression study findings from University of Western Australia
2009 AUG 3 ... in neonates exposed to citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine or sertraline (SSRI's), or to venlafaxine (an SNRI). Women receiving antidepressants during pregnancy ...
Subject: Depression
Price: $3.00
*
Research from University of Pittsburgh, Western Psychiatric Institute reveals new findings on depression
2009 SEP 28 ... of Pittsburgh, Western Psychiatric Institute. The researchers concluded: "Sertraline, paroxetine, nortriptyline, and imipramine are the most evidence-based medications for ...
Subject: Depression
Price: $3.00
*
Research on depression reported by M. Nechifor et al
2009 NOV 2 ... mechanisms of action, such as amytriptiline (25 mg x 3/day per os, 4 weeks) and sertraline (50 mg x 3/day per os, 4 weeks) leads to a significant increase of magnesium ...
Subject: Depression
Price: $3.00
*
Research on heart disease published by A.H. Glassman et al
2009 OCT 5 ... is associated with an increased mortality rate. We observed the participants of the Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) to establish features of MDD ...
Subject: Heart Disease
Price: $3.00
*
Research results from G. Bahrami and co-authors update knowledge of chromatography
2009 AUG 25 ... sensitive reversed-phase high-performance liquid chromatographic method for analysis of sertraline in human serum, using 4-chloro-7-nitrobenzofurazan as pre-column derivatization agent, ...
Subject: Chromatography
Price: $3.00
*
Studies by B.S. Meyers and co-authors describe new findings in clinical trial research
2009 AUG 31 ... geriatric participants). Target doses of 15 to 20 mg of olanzapine per day plus masked sertraline or placebo at 150 to 200 mg per day. Remission rates of MD with psychotic features. ...
Subject: Clinical Trial Research
Price: $3.00
*
Studies from University of Virginia add new findings in the area of anxiety disorders
2009 SEP 28 ... "Sertraline has been used as a treatment for anxiety disorders since the mid 1990s and has proven ...
Subject: Anxiety Disorders
Price: $3.00
*
Studies from Washington University, Medical Department provide new data on coronary heart disease
2009 NOV 16 ... with omega-3 fatty acids. To determine whether omega-3 improves the response to sertraline in patients with major depression and coronary heart disease (CHD). Randomized ...
Subject: Coronary Heart Disease
Price: $3.00
*
Study findings on depression are outlined in reports from Yale University
2009 OCT 5 ... used antidepressant agents. Several of these drugs, including imipramine, citalopram, sertraline, and fluoxetine (Prozac), bound more avidly to SERT in the presence of Cl-." ...
Subject: Depression
Price: $3.00
*
Use of omega-3 with treatment for depression in heart disease patients may not provide benefit
2009 NOV 2 ... trial to examine whether omega-3 improves the efficacy of the antidepression medication sertraline for patients with CHD and major depression. The study included 122 patients, who ...
Subject: JAMA and Archives Journals
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login